Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

ConditionWrinkle
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-70
SponsorCytrellis Biosystems, Inc.

About this trial

Study evaluating the efficacy of a micro coring device for the treatment of moderate to severe check wrinkles

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Males and females 40-70 years of age

Fitzpatrick Skin Type I to IV as judged by the Investigator

Cheek areas are at least a score of 3 using the Lemperle Wrinkle Assessment Scale as judged by the Investigator

Able to provide written informed consent, understand and willing to comply with all study related procedures and follow-up visits.

Disqualifiers

Lesions suspicious for any malignancy or the presence of actinic keratosis, melasma, vitiligo, cutaneous papules/nodules or active inflammatory lesions in the areas to be treated

History of keloid formation or hypertrophic scarring

History of trauma or surgery to the treatment areas in the past 6 months

Scar present in the areas to be treated

Trial design

Design model

Single group

Treatments tested in this trial

  • MCD

    Device

    Micro coring skin removal with automated coring device

Treatment groups

35 Participants
are divided into 1 treatment group
Group A: Micro-exisional skin removalExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Assess level of wrinkle improvement using the Lemperle Wrinkle Severity Scale

A mean change of 1 point or greater reduction in cheek wrinkle severity at 90 days post treatment using the Lemperle Wrinkle Severity Scale, as assessed by (3) blinded Independent Reviewers Lemperle Scale: No wrinkles =0 Just perceptible wrinkles =1 Shallow wrinkles=2 Moderately deep wrinkles=3 Deep wrinkles, well-defined edges =4 Very deep wrinkles, redundant fold=5

Time frame
90 day post treatment

Secondary outcomes

1

Assess aesthetic improvement using Global Aesthetic Improvement Scale

Overall aesthetic improvement level per Principal Investigator at 90 days compared to baseline on the Global Aesthetic Improvement Scale. Very Much Improved (Optimal cosmetic result)=3 Much Improved (Marked improvement from the initial condition, but not completely optimal)=2 No Change (The appearance is essentially the same as baseline)=0 Worse (The appearance is worse than the original condition)= -1 Much Worse (Marked worsening in appearance from the initial condition)= - 2 Very Much Worse (Obvious worsening in appearance from the initial condition)=- 3

Time frame
90 day post treatment
2

Assess aesthetic improvement using Subject Satisfaction Scale

Satisfaction with the aesthetic appearance of the treatment area per Subject Satisfaction Scale compared to baseline. Extremely dissatisfied=0 Somewhat dissatisfied=1 Slightly dissatisfied=2 Neither satisfied or dissatisfied=3 Slightly satisfied=4 Somewhat satisfied=5 Extremely satisfied=6

Time frame
90 day post treatment
3

Assess aesthetic improvement in wrinkles using OCT images (optional)

Assessment of improvement using OCT images with Vista software to determine wrinkle depth reduction, comparing pre-treatment depth to post treatment depth.

Time frame
Baseline to Day 90 post treatment
4

Assess efficacy results using Canfield Software,, by comparing the changes in wrinkles at baseline and 90 days post treatment.

Validated Canfield software comparing baseline wrinkles to day 90 follow up wrinkles via automated photo analysis.

Time frame
Baseline to Day 90 post treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.